PL364053A1 - Naphtothiazine positive allosteric ampa receptor modulators (paarm) - Google Patents

Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Info

Publication number
PL364053A1
PL364053A1 PL02364053A PL36405302A PL364053A1 PL 364053 A1 PL364053 A1 PL 364053A1 PL 02364053 A PL02364053 A PL 02364053A PL 36405302 A PL36405302 A PL 36405302A PL 364053 A1 PL364053 A1 PL 364053A1
Authority
PL
Poland
Prior art keywords
paarm
naphtothiazine
receptor modulators
positive allosteric
ampa receptor
Prior art date
Application number
PL02364053A
Other languages
English (en)
Polish (pl)
Inventor
Angelo Ceci
Klaus Klinder
Thomas Weiser
Karin Winter
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg
Publication of PL364053A1 publication Critical patent/PL364053A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
PL02364053A 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators (paarm) PL364053A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10123952A DE10123952A1 (de) 2001-05-17 2001-05-17 Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
PCT/EP2002/005338 WO2002100411A1 (en) 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Publications (1)

Publication Number Publication Date
PL364053A1 true PL364053A1 (en) 2004-12-13

Family

ID=7685080

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02364053A PL364053A1 (en) 2001-05-17 2002-05-15 Naphtothiazine positive allosteric ampa receptor modulators (paarm)

Country Status (26)

Country Link
EP (1) EP1404340A1 (xx)
JP (1) JP2004529980A (xx)
KR (1) KR20040007572A (xx)
CN (1) CN1533278A (xx)
AR (1) AR036332A1 (xx)
BG (1) BG108324A (xx)
BR (1) BR0209796A (xx)
CA (1) CA2449189A1 (xx)
CO (1) CO5550460A2 (xx)
CZ (1) CZ20033112A3 (xx)
DE (1) DE10123952A1 (xx)
EA (1) EA006608B1 (xx)
EC (1) ECSP034852A (xx)
EE (1) EE200300566A (xx)
HR (1) HRP20030933A2 (xx)
HU (1) HUP0401273A3 (xx)
IL (1) IL158642A0 (xx)
MX (1) MXPA03010373A (xx)
NO (1) NO20035088L (xx)
NZ (1) NZ530154A (xx)
PL (1) PL364053A1 (xx)
SK (1) SK14222003A3 (xx)
UY (1) UY27290A1 (xx)
WO (1) WO2002100411A1 (xx)
YU (1) YU90403A (xx)
ZA (1) ZA200308466B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090047534A (ko) * 2006-08-31 2009-05-12 더 거버너스 오브 더 유니버시티 오브 앨버타 양성 알로스테릭 ampa 수용체 조절인자를 사용하여 호흡 저하를 억제하는 방법
CN111518058B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种噁噻嗪类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
JP2002518498A (ja) * 1998-06-25 2002-06-25 メルク エンド カムパニー インコーポレーテッド ナフト[1,8−de]チアジン−2−イルメチルカルバペネム抗菌物質
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
CN1533278A (zh) 2004-09-29
SK14222003A3 (sk) 2004-05-04
AR036332A1 (es) 2004-09-01
NZ530154A (en) 2005-09-30
ZA200308466B (en) 2004-05-24
MXPA03010373A (es) 2004-03-16
CZ20033112A3 (en) 2004-03-17
CO5550460A2 (es) 2005-08-31
BG108324A (bg) 2004-12-30
HUP0401273A2 (hu) 2004-10-28
IL158642A0 (en) 2004-05-12
CA2449189A1 (en) 2002-12-19
KR20040007572A (ko) 2004-01-24
HRP20030933A2 (en) 2004-04-30
ECSP034852A (es) 2003-12-24
JP2004529980A (ja) 2004-09-30
NO20035088D0 (no) 2003-11-14
NO20035088L (no) 2003-11-14
UY27290A1 (es) 2002-12-31
EA200301167A1 (ru) 2004-06-24
BR0209796A (pt) 2004-06-01
EP1404340A1 (en) 2004-04-07
DE10123952A1 (de) 2002-11-21
EE200300566A (et) 2004-02-16
WO2002100411A1 (en) 2002-12-19
HUP0401273A3 (en) 2006-11-28
EA006608B1 (ru) 2006-02-24
YU90403A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
IL158038A0 (en) Allosteric adenosine receptor modulators
IL150912A0 (en) Adenosine receptor modulators
GB2384570B (en) Modulators
AU2003245773A1 (en) Vanilloid receptor modulators
AU2003265128A8 (en) Positive allosteric modulators of the nicotinic acetylcholine receptor
IL159594A0 (en) Adenosine a3 receptor modulators
PL375559A1 (en) Calcium receptor modulating agents
HK1066544A1 (en) ImidazoÄ1,5-AÜpyrimido Ä5,4-DÜ benzazepine derivatives as gaba a receptor modulators
AU2003237492A1 (en) Urotensin ii receptor modulators
GB0123379D0 (en) Modulators
AU2002365655A1 (en) 5-ht7 receptor antagonists
AU2002357219A8 (en) Frequency-down-converter using sigma-delta modulators
EP1581309A4 (en) KINASE MODULATORS
IL158642A0 (en) Naphthothiazine positive allosteric ampa receptor modulators (paarm)
GB0102876D0 (en) Triboluminescent devices
AU2002366012A1 (en) Transferring device
PL370980A1 (en) Benzothiophenes as adenosine receptor modulators
GB2388034B (en) Fixing devices for prosthetic devices
AU2002249304A1 (en) Novel human gnrh receptor
GB0106338D0 (en) Electro-optic modulators
GB0111959D0 (en) Receptor
GB0125183D0 (en) Receptor
GB0114929D0 (en) Receptor
GB0110662D0 (en) Receptor
AU2002233126A1 (en) Walking mechanism for bionics devices

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)